Seasoned, Systematic, Successful
Deals / Tombstones: Corporate Finance / MTS Medication Technologies
Deals

This announcement appears as a matter of record only


MTS Medication Technologies

Received $13,000,000 for working capital from

LaSalle Bank and Berwind Growth Capital

FOCUS Partner James C. Harper assisted in the negotiations as the representative of MTS Medication Technologies.

Complimentary,
middle market monthly email newsletter. Relevant insights, trends, and news. Substance, not fluff.
more information....

Read more about FOCUS Enterprises' various business sector experience... Read More


The FOCUS Capabilities Brochure ...Download


Securities transactions are conducted through Wm. H. Murphy & Co., Inc. a registered broker-dealer member FINRA/SIPC that is not affiliated with FOCUS.

Home | About Us | Services | Sectors | Deals | FOCUS Funds
Publications | News | Privacy Policy | Site Map | Contact Us